Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesFluoxetine and imipramine: are there differences in cost-utility for depression in primary care
Journal of Evaluation in Clinical Practice, 02/25/09
Serrano-Blanco A et al. - Taking into account adjusted total costs and incremental quality of life gained, imipramine dominated fluoxetine with 81.5% of the bootstrap replications in the dominance quadrant. Imipramine seems to be a better cost-utility antidepressant option for treating depressive disorders in primary care.
Related Articles
Review: differences in efficacy and acceptability exist for 12 new-generation antidepressants for major depression
Evidence-Based Medicine, 10/26/09
Relevance Score: 43%
Trends in prescribing and self-poisoning in relation to UK regulatory authority warnings against use of SSRI antidepressants in under-18-year-olds
British Journal of Clinical Pharmacology, 11/02/09
Relevance Score: 41%
Use of Antidepressants for Management of Hot Flashes
Pharmacotherapy, 10/27/09
Relevance Score: 40%
Persistent Idiopathic Facial Pain
Pain Practice, 10/30/09
Relevance Score: 39%
Today in Economics of Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Willingness to Pay for Maternal Health Outcomes: Are Women Willing to Pay More than Men
Applied Health Economics and Health Policy, 03/01/10
The changing economy may mean a change in plans
Physicians Practice, 02/26/10
The interface between residential aged care and the emergency department: a systematic review
Age and Aging, 02/25/10
Article Search
Sponsor
Sponsor